How much does a box of lapatinib cost?

Lapatinib (Lapatinib), trade name is Telisa, is a new targeted treatment drug for breast cancer developed by the British company GlaxoSmithKline. It is a tyrosine kinase inhibitor that specifically inhibits the tyrosine kinase activity of human epidermal growth factor receptor-1 (ErbB1) and human epidermal growth factor receptor-2 (ErbB2), thereby blocking the growth signals of tumor cells and achieving anti-tumor effects.

Lapatinib is mainly used to treat advanced or metastatic breast cancer with overexpression of HER2 (ErbB2), especially for patients who are resistant to traditional therapies such as anthracyclines, paclitaxel, and trastuzumab (Herceptin). In clinical application, lapatinib is often used in combination with chemotherapy drugs such as capecitabine to enhance the therapeutic effect. The recommended dose is 1250 mg per day, taken for 21 consecutive days and stopped for 7 days to form a treatment cycle.

The launch of lapatinib provides new treatment options for breast cancer patients, especially in cases of resistance to traditional therapies. It can block the growth and spread of tumor cells by inhibiting the HER2 signaling pathway, thereby prolonging patients' survival and improving their quality of life. However, long-term use of lapatinib may also cause some side effects, such as nausea, diarrhea, rash, stomatitis, etc. Therefore, it is necessary to closely monitor the patient's condition changes and the efficacy and side effects of the drug during use.

In terms of price, the original drug of lapatinib is relatively expensive, but generic drugs have also been launched in some countries with relatively low prices. For patients who require lapatinib treatment, they can consult professional medical personnel or institutions for more detailed information and medication guidance.

In summary, lapatinib is an important targeted therapy for breast cancer, providing new treatment hope and options for patients with advanced or metastatic breast cancer overexpressing HER2.

Up to now, the original drug of lapatinib has been launched globally, and its domestic specifications areIt is packed with 70 tablets, each tablet is 250mg, and the price is about 6,000 yuan. In addition, as far as we know, there are also related generic versions of lapatinib on the market in India and Bangladesh, with the price of a 30-tablet generic version ranging from about 600 to 900 yuan. Patients who need to purchase generic versions can consult professional overseas medical consulting agencies.